GMO US Value ETF
GMOV
20 hedge funds and large institutions have $33.8M invested in GMO US Value ETF in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 3 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
33% more capital invested
Capital invested by funds: $25.4M → $33.8M (+$8.33M)
5.47% more ownership
Funds ownership: 32.33% → 37.8% (+5.5%)
5% more funds holding
Funds holding: 19 → 20 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Commerce Advisors
Memphis,
Tennessee
|
+$4.84M |
| 2 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
+$907K |
| 3 |
Goldman Sachs
New York
|
+$532K |
| 4 |
SG
StoneX Group
New York
|
+$452K |
| 5 |
EP
Essential Partners
Rancho Santa Fe,
California
|
+$388K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$327K |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$288K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$275K |
| 4 |
MML Investors Services
Springfield,
Massachusetts
|
-$257K |
| 5 |
Cerity Partners
New York
|
-$198K |
GMOV Hedge Fund Activity: Q2 2026 in Review
20 of the 8,316 institutional investors tracked by Wall St. Rank reported a position in GMO US Value ETF (GMOV) for Q2 2026, worth a combined $33.8M — up 33% from $25.4M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GMOV positions and 3 closed out — a net gain of 1 holder — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Commerce Advisors, adding an estimated $4.84M. The largest seller was Citadel Advisors, exiting entirely with an estimated $327K sold.
- 20 institutional investors held GMO US Value ETF (GMOV) as of Q2 2026, up from 19 in Q1 2026.
- Funds reported $33.8M of GMO US Value ETF stock for Q2 2026, up 33% quarter-over-quarter.
- 4 funds opened new GMO US Value ETF positions in Q2 2026 and 3 closed out, a net change of +1 holder.
- The largest GMO US Value ETF buyer in Q2 2026 was Commerce Advisors, an estimated $4.84M added.
- The largest GMO US Value ETF seller in Q2 2026 was Citadel Advisors, an estimated $327K sold.
Based on aggregated 13F filings for Q2 2026.